摘要 |
Disclosed are antibodies that interact with a matrix metalloproteases such as MMP-26. Exemplary antibodies inhibit MMP-26 activity. These antibodies can be used, e.g., to treat or prevent metastatic disorders, hyperproliferative disorders, disorders which are characterized by excessive extracellular matrix degradation, and inflammatory disorders. |
申请人 |
DYAX CORP.;DRANSFIELD, DANIEL, T.;ROOKEY, KRISTEN;LADNER, ROBERT, C. |
发明人 |
DRANSFIELD, DANIEL, T.;ROOKEY, KRISTEN;LADNER, ROBERT, C. |